Lim T K, Chin N K
Dept of Medicine, National University Hospital, Singapore, Singapore.
Eur Respir J. 1999 Mar;13(3):514-8. doi: 10.1183/09031936.99.13351499.
The efficacy of three different treatment protocols was compared: 1) simple chest tube drainage (Drain); 2) adjunctive intrapleural streptokinase (IP-SK); and 3) an aggressive empirical approach incorporating SK and early surgical drainage (SK+early OP) in patients with pleural empyema and high-risk parapneumonic effusions. This was a nonrandomized, prospective, controlled time series study of 82 consecutive patients with community-acquired empyema (n=68) and high-risk parapneumonic effusions (n=14). The following three treatment protocols were administered in sequence over 6 years: 1) Drain (n=29, chest catheter drainage); 2) IP-SK (n=23, adjunctive intrapleural fibrinolysis with 250,000 U x day(-1) SK); and 3) SK+early OP (n=30, early surgical drainage was offered to patients who failed to respond promptly following initial drainage plus SK). The average duration of hospital stay in the SK+early OP group was significantly shorter than in the Drain and IP-SK groups. The mortality rate was also significantly lower in the SK+early OP than the Drain groups (3 versus 24%). It was concluded that an empirical treatment strategy which combines adjunctive intrapleural fibrinolysis with early surgical intervention results in shorter hospital stays and may reduce mortality in patients with pleural sepsis.
1)单纯胸腔闭式引流(引流组);2)辅助胸腔内注射链激酶(IP-SK组);3)对于胸腔积脓和高危类肺炎性胸腔积液患者,采用联合链激酶和早期手术引流的积极经验性方法(SK+早期手术组)。这是一项针对82例连续的社区获得性胸腔积脓患者(n=68)和高危类肺炎性胸腔积液患者(n=14)的非随机、前瞻性、对照时间序列研究。在6年时间里依次采用了以下三种治疗方案:1)引流组(n=29,胸腔导管引流);2)IP-SK组(n=23,每日辅助胸腔内注射250,000 U链激酶进行纤维蛋白溶解);3)SK+早期手术组(n=30,对于初始引流加链激酶治疗后未迅速起效的患者进行早期手术引流)。SK+早期手术组的平均住院时间显著短于引流组和IP-SK组。SK+早期手术组的死亡率也显著低于引流组(3%对24%)。得出的结论是,联合辅助胸腔内纤维蛋白溶解与早期手术干预的经验性治疗策略可缩短住院时间,并可能降低胸膜脓毒症患者的死亡率。